| Symbol | CJMB |
|---|---|
| Name | CALLAN JMB INC. |
| Sector | CONSUMER DISCRETIONARY |
| Region | North America |
| Industry | Business Services |
| Address | 244 FLIGHTLINE,DRIVE, SPRING BRANCH, Texas, 78070, United States |
| Telephone | (830) 438-0395 |
| Fax | — |
| — | |
| Website | https://www.coldchain-tech.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | — |
| Description | Callan JMB is a vertically integrated logistics and fulfillment company which provides thermal management logistics solutions to the life sciences industry through a combination of proprietary packaging, information technology and specialized cold chain logistics knowhow. We provide a system that utilizes advanced predictive technology to revolutionize the supply chain by guaranteeing the safety, effectiveness, and potency of every product handled to ensure product integrity, and to provide immediate response in time-sensitive industries while ensuring environmental responsibility. As part of our services, we provide the ability to monitor, record and archive crucial information for each shipment that can be used for scientific and regulatory purposes. Additional info from NASDAQ: |
Callan JMB Issues Statement on Recently Filed Lawsuit by Eddie Patent Holdings LLC
Read moreCallan JMB Successfully Deploys Rapid Redistribution of Critical Pharmaceuticals to Combat Localized Disease Outbreaks for Longstanding Customer
Read moreCallan JMB Reports Full Year 2025 Financial Results and Provides Business Update
Read moreCallan JMB Supports U.S. Scale-Up of Multi-Indication Immune Platform with Phase 2b/3 Advancement
Read moreCroyle David J 🟢 acquired 10.2K shares of CALLAN JMB INC. (CJMB) at $1.75 Transaction Date: Mar 20, 2026 | Filing ID: 013014
Read moreCallan JMB Inc. to Oversee Manufacturing and Quality Control of Attune Biotech’s IND Clinical Trials for lodonal™ in the Treatment of Long COVID
Read more